IBA catalog GB int60p 10 v9 - IBA Molecular
IBA catalog GB int60p 10 v9 - IBA Molecular
IBA catalog GB int60p 10 v9 - IBA Molecular
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
INTERNATIONAL CATALOGUE ALOGUE<br />
I-131-S-1<br />
Iodine-131 T1/2 = 8.02 d SODIUM IODIDE ( 131 I) ORAL SOLUTION<br />
Availability<br />
Ordering deadline<br />
Radioactive concentration<br />
Calibration<br />
Available quantities<br />
Expiry<br />
Specific activity at calibration<br />
Radiochemical purity<br />
Radionuclidic purity at calibration<br />
pH and composition<br />
Storage<br />
Indication<br />
I-131-S-2<br />
20 | <strong>IBA</strong> |<br />
Tuesday<br />
Friday, before 11 a.m.<br />
11<strong>10</strong> MBq/ml (30 mCi/ml) at calibration date<br />
Wednesday (following week) 12 a.m.<br />
From 11<strong>10</strong> to 11 <strong>10</strong>0 MBq<br />
29 days after the manufacturing date<br />
� 185 <strong>GB</strong>q/mg iodine<br />
Iodide : � 95 %<br />
� 99.9 %; 133 I + 135 I + other alpha impurities � 0.1 %<br />
7 - <strong>10</strong> in sterile solution with carbonate-thiosulfate buffer<br />
Not above 25°C<br />
Diagnostic<br />
• Estimation of thyroid uptake and effective half life<br />
• Identification of thyroid remnant and metastases (after ablation)<br />
Therapy<br />
• Treatment of Graves’ disease, toxic multinodular goitre or<br />
autonomous nodules<br />
• Treatment of papillary and follicular thyroid carcinoma including<br />
metastatic disease<br />
Iodine-131 T1/2 = 8.02 d SODIUM IODIDE ( 131 I) SOLUTION FOR INJECTION<br />
Availability<br />
Ordering deadline<br />
Radioactive concentration<br />
Calibration<br />
Available quantities<br />
Expiry<br />
Specific activity<br />
Radiochemical purity<br />
Radionuclidic purity at calibration<br />
pH and composition<br />
Storage<br />
Indication<br />
Thursday<br />
2 days before the shipment day, before <strong>10</strong> a.m.<br />
111 MBq/ml (3 mCi/ml)<br />
Friday (following week) 12 a.m.<br />
From 74 to 11<strong>10</strong> MBq<br />
29 days after the manufacturing date<br />
� 185 <strong>GB</strong>q/mg at calibration<br />
Iodide : � 95 %<br />
� 99.9 %; 133 I + 135 I + other alpha impurities � 0.1 %<br />
6 - 8 in phosphate-thiosulfate buffer<br />
Not above 25°C<br />
Diagnostic<br />
• Estimation of thyroid uptake and effective half life<br />
• Management of thyroid carcinoma : identification of thyroid remnant<br />
and metastases (after ablation)<br />
Therapy<br />
• Treatment of Graves disease, toxic multinodular goitre or<br />
autonomous nodules<br />
• Treatment of papillary and follicular thyroid carcinoma including<br />
metastatic disease
Change language